SILO Pharma Inc
SILO
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.73M
Close$
$6.46
40.3% upside
Current Fair Value
40.3% upsideUndervalued by 40.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $4.73 Million |
|---|---|
| Enterprise Value | $898,464.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-7.5 |
| Beta | 0.75 |
| Outstanding Shares | 913,947 |
Return
| Return on Equity | -85.24% |
|---|---|
| Return on Assets | -69.01% |
| Return on Invested Capital | -75.87% |
Valuation & Multiples
| P/E Ratio | -0.56 |
|---|---|
| PEG | -0.94 |
| Price to Sales | - |
| Price to Book Ratio | 0.77 |
| Enterprise Value to Revenue | 12.46 |
| Enterprise Value to EBIT | -0.19 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 14, 2026
EPS Estimate
$-0.32
Average shareholder expectationRevenue Estimate
$18,000
Average shareholder expectationNext Earnings Call
Expected Date
September 2, 2026
EPS Estimate
$-0.32
Average shareholder expectationRevenue Estimate
$18,000
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 7.70%▼ 1.41% |
|---|---|
| Total Invested | $379,779▼ 7.90% |
| Investors Holding | 14▼ 1.00% |
ESG Score
No data
About SILO Pharma Inc
1 employees